Antikor is a privately-held biotechnology company originally spun-out from Imperial College. We specialise in the discovery and development of small-format Antibody (Fragment) Drug Conjugates, known as FDCs. FDCs are a form of targeted cytotoxic chemotherapy combining the specificity of antibodies with the potency of small-molecule chemotherapy drugs. Specifically, FDCs are smaller than conventional Antibody Drug Conjugates (ADCs) meaning better tumour penetration and more rapid systemic clearance, potentially leading to a higher clinical therapeutic index. Antikor are developing the next-generation of solid tumour therapies, with a major interest in gastro-intestinal cancers.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Gunnels Wood Road, Stevenage,england Sg12fx,united Kingdom
- Phone
- 4401438906906
- en****@****r.co.uk
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- antikor.co.uk
- HQ
- Stevenage, England
Antikor Biopharma Ltd Questions
Antikor Biopharma Ltd's helpline number is 4401438906906
Antikor Biopharma Ltd's website is antikor.co.uk
Antikor Biopharma Ltd's LinkedIn profile is https://uk.linkedin.com/company/antikor-biopharma-ltd
Antikor Biopharma Ltd has
11 employees.
View email and phone details for 11
employees at Antikor Biopharma Ltd.
Antikor Biopharma Ltd's industry is
Biotechnology Research
Antikor Biopharma Ltd's top competitors are
Tessellate Bio,
Autifony Therapeutics,
Stevenage Bioscience Catalyst,
Vasodynamics Ltd,
Apexomic,
Pear Bio,
Pharmidex,
Myricx Bio,
Genevation Ltd,
Bioarchitech Ltd.
Antikor Biopharma Ltd's support email address is enquiries@antikor.co.uk
Antikor Biopharma Ltd's categories are Biotechnology Research
Antikor Biopharma Ltd's founding year is 2014
